Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Sophia Genetics' CFTR Test

Premium

Sophia Genetics has launched a CE-IVD marked, next-generation sequencing-based cystic fibrosis test. According to the company, it has developed a statistical method that enables copy number detection, as well as a realignment algorithm to detect variants in the polyT and polyTG stretches of intron 8 and to distinguish between various combinations of repeat lengths, which enables the test to identify and characterize all types of variants in a single NGS run.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.